ABOUT THIS EVENT
Silverback Therapeutics (Nasdaq: SBTX), a Seattle-based, clinical-stage biopharmaceutical company focused on developing systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases, rings the Nasdaq Closing Bell remotely from across the country.
Laura Shawver, Ph.D., CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.